Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Emulate raises $28mm in Series B round; later expands round with an additional $17mm

Executive Summary

Organs-on-Chips company Emulate Inc. raised $28mm in its Series B financing round. Existing investors Hansjörg Wyss, NanoDimension, and Cedars-Sinai Medical Center were joined by new investors OS Fund, Atel Ventures, the Leandro P. Rizzuto Foundation (ALS Finding a Cure), and Laboratory Corp of America Holdings. Proceeds will be used to advance the company's product design and development including for the launch of the Human Emulation System; for expansion of the Organ-Chip portfolio beyond liver, lung, intestine and skin; and for acceleration of disease-state applications for Organ-Chips.
Deal Industry
  • Medical Devices
  • Biotechnology
    • Drug Discovery Tools
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies